Form 4: ClearPoint Neuro COO Mazin Sabra Acquires Shares Through Employee Stock Purchase Plan

ClearPoint Neuro, Inc.'s Chief Operating Officer, Mazin Sabra, acquired 361 shares of common stock at $10.15 per share through the company's Employee Stock Purchase Plan.

Summary

• Mazin Sabra, Chief Operating Officer of ClearPoint Neuro, Inc. (CLPT), acquired 361 shares of the company's common stock.
• The acquisition occurred on June 30, 2025, at a price of $10.15 per share.
• This transaction was made pursuant to the company's Employee Stock Purchase Plan (ESPP) for the purchase period spanning January 1, 2025, through June 30, 2025.
• Shares were purchased at 85% of the fair market value on either the first or last day of the purchase period, whichever was lower.
• Following this transaction, Mazin Sabra beneficially owns a total of 51,564 shares of ClearPoint Neuro common stock.

Sentiment

Score: 7

Explanation: The acquisition of shares by a Chief Operating Officer through an Employee Stock Purchase Plan is generally a positive signal, indicating insider confidence and alignment of interests. The transaction itself is routine for an ESPP, but the insider buying is a favorable indicator.

Positives

• Insider acquisition of shares, indicating management's confidence in the company's future prospects.
• Participation in the Employee Stock Purchase Plan (ESPP) demonstrates alignment of employee interests with shareholder interests.
• The purchase price of $10.15 per share, acquired at a discount (85% of fair market value), suggests a favorable entry point for the insider.

Future Outlook

The document does not provide specific forward-looking statements or guidance beyond the details of the stock acquisition.

Management Comments

• The reporting person is voluntarily reporting the acquisition of the Issuer's common stock pursuant to the Employee Stock Purchase Plan ('ESPP'), for the ESPP purchase period of January 1, 2025 through June 30, 2025.
• In accordance with the ESPP, these shares were purchased at the lesser of 85% of the fair market value on either the first day or last day of the purchase period.

Industry Context

This insider purchase by a key executive at ClearPoint Neuro, a medical device company specializing in neuro-navigation systems, aligns with a broader trend of management confidence in companies within the growing neuro-technology and minimally invasive surgery sectors. While a single transaction, it can be viewed as a positive signal within an industry focused on innovation and long-term growth.

Comparison to Industry Standards

• Employee Stock Purchase Plans (ESPPs) are a common benefit offered by publicly traded companies across various industries, including medical technology, to encourage employee ownership and align interests with shareholders.
• The discount rate of 15% (85% of fair market value) offered in ClearPoint Neuro's ESPP is typical for such plans, which often range from 5% to 15% discounts on the stock price.
• Insider purchases, especially by C-suite executives like a COO, are generally viewed favorably by investors as they signal belief in the company's future performance, a sentiment consistent with similar transactions observed in peer companies within the medical device space.

Related Party Transactions

• Acquisition of common stock by Chief Operating Officer Mazin Sabra through the company's Employee Stock Purchase Plan (ESPP), which is a transaction between an insider and the company.

Stakeholder Impact

• Shareholders: Positive signal due to insider buying, potentially increasing investor confidence.
• Employees: Reinforces the value of the Employee Stock Purchase Plan as a benefit and encourages employee ownership.
• Management: Demonstrates commitment and alignment with company performance.

Next Steps

• Continued participation in future Employee Stock Purchase Plan periods, if applicable.
• Potential future insider transactions (acquisitions or dispositions) by Mazin Sabra or other ClearPoint Neuro insiders.

Key Dates

Recommendation

Keywords

ClearPoint Neuro, CLPT, Mazin Sabra, Chief Operating Officer, COO, SEC Form 4, Insider Trading, Stock Acquisition, Employee Stock Purchase Plan, ESPP, Common Stock, Beneficial Ownership